Johanna Eichinger

Johanna Eichinger

Auto-generated profile, based on publicly available information

Johanna Eichinger

Institute for Biomedical Ethics, University of Basel, Basel, Switzerland

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2021 in Social Science & Medicine
Verified
Journal Article
Closed access
AFAmelia Fiske
Amelia Fiske
IGIlaria Galasso
Ilaria Galasso
JEJohanna Eichinger
Johanna Eichinger
SMStuart McLennan
Stuart McLennan
IRIsabella Radhuber
Isabella Radhuber
BPBarbara Prainsack
Barbara Prainsack

6 September 2021 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
JEJohanna Eichinger
Johanna Eichinger
BEBernice S. Elger
Bernice S. Elger
IKInsa Koné
Insa Koné
IFIsabel Filges
Isabel Filges
DSDavid Shaw
David Shaw
SMStuart McLennan
Stuart McLennan
Background: The use of genome-wide sequencing in pediatric medicine and research is growing exponentially. While this has many potential benefits, the normative and empirical literature has highlighted various ethical issues. There have not been, however, any systematic reviews of these issues. The aim of this systematic review is to determine systematically the spectrum of ethical issues that is raised for stakeholders in in pediatric genome-wide sequencing.Methods: A systematic review in PubMed and Google Books (publications in English or German between 2004 and 2021) was conducted. Further references were identified via reference screening. Data were analyzed and synthesized using qualitative content analysis. Ethical issues were defined as arising when a relevant normative principle is not adequately considered or when two principles come into conflict.Results: Our literature search retrieved 3175 publications of which 143 were included in the analysis. Together these mentioned 106 ethical issues in pediatric genome-wide sequencing, categorized into five themes along the pediatric genome-wide sequencing lifecycle. Most ethical issues identified in relation to genome-wide sequencing typically reflect ethical issues that arise in general genetic testing, but they are often amplified by the increased quantity of data obtained, and associated uncertainties. The most frequently discussed ethical aspects concern the issue of unsolicited findings.Conclusion: Concentration of the debate on unsolicited findings risks overlooking other ethical challenges. An overarching difficulty presents the terminological confusion: both with regard to both the test procedure/ the scope of analysis, as well as with the topic of unsolicited findings. It is important that the genetics and ethics communities together with other medical professions involved work jointly on specific case related guidelines to grant the maximum benefit for the care of the children, while preventing patient harm and disproportionate overload of clinicians and the healthcare system by the wealth of available options and economic incentives to increase testing.


29 September 2023 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
JEJohanna Eichinger
Johanna Eichinger
BZBettina Zimmermann
Bettina Zimmermann
BEBernice Elger
Bernice Elger
SMStuart McLennan
Stuart McLennan
IFIsabel Filges
Isabel Filges
IKInsa Koné
Insa Koné
The use of genome-wide sequencing (GWS) in paediatrics has added complexity to informed consent (IC) and pretest counselling because of the vast number and interpretation of potential findings, and their implications. However, empirical data from continental Europe on these issues remains limited. This study therefore aimed to explore the experiences and views of medical geneticists working with children in Germany and Switzerland regarding the challenges of obtaining valid IC in paediatric GWS. Qualitative interviews with 20 medical geneticists were analysed employing reflexive thematic analysis. In the interviews, many medical geneticists questioned the validity of parents’ IC due to the enormous amount of relevant information given and the variety and complexity of the possible test outcomes. Key barriers identified included familial implications, administrative challenges and struggles with non-directiveness. Medical geneticists’ suggestions for improvement included increasing the number of genetics professionals and better information material, which is crucial as GWS becomes a diagnostic standard in the early care pathways of children. An adjustment of aspirations from still existing ideal of traditional fully IC to appropriate IC seems to be needed. Such a more realistic and ethically sound adaptation of the requirements for IC can lead to better ‘informedness’ and improve the validity of the consent. This might also help reduce the moral distress for the medical geneticists involved.

23 January 2024 in Health Care Analysis
Verified
Journal Article
Open access
PDF file
JEJohanna Eichinger
Johanna Eichinger
ABAndrea Büchler
Andrea Büchler
LALouisa Arnold
Louisa Arnold
MRMichael Rost
Michael Rost
Evidence shows that during birth women frequently experience unconsented care, coercion, and a loss of autonomy. For many countries, this contradicts both the law and medical ethics guidelines, which emphasize that competent and fully informed women’s autonomy must always be respected. To better understand this discordance, we empirically describe perinatal maternity care providers’ and women’s moral deliberation surrounding coercive measures during birth. Data were obtained from 1-on-1 interviews with providers (N = 15) and women (N = 14), and a survey of women (N = 118). Analyses focused on an in-depth exploration of responses to a question on the permissibility of coercion in birth whose wording was borrowed from a Swiss medical-ethical guideline. Reasons for and against a principle permissibility of coercive measures in birth were grouped into clusters of reasons to build a coherent explanatory framework. Factors considered morally relevant when deliberating on coercion included women’s decisional capacity, beneficence/non-maleficence, authority through knowledge on the part of providers, flaws of the medical system, or the imperative to protect the most vulnerable. Also, we identified various misconceptions, such as the conviction that a pathological birth can justify coercion or that fetal rights can justifiably infringe on women’s autonomy. Information and education on the issue of coercion in birth are urgently needed to enable women to fully exercise their reproductive autonomy, to prevent long-term adverse health outcomes of women and children, and to reconcile the medical vigilance which has lead to a reduction of perinatal morbidity and mortality with women’s enfranchisement in their own care.

14 November 2025 in SSM - Qualitative Research in Health
Verified
Journal Article
Open access
ZSZ. Stuerner
Z. Stuerner
MRM. Rost
M. Rost
LAL. Arnold
L. Arnold
JEJ. Eichinger
J. Eichinger